Henan Cancer Hospital

This study is testing whether adding a new immunotherapy drug called camrelizumab to standard chemotherapy (AVD) works better for people with advanced Hodgkin's lymphoma who haven't had treatment before. The trial will enroll 60 patients to see if this combination helps more peop…

This study is testing a combination of three drugs to see if they can shrink advanced stomach tumors enough for surgeons to remove them completely. It is for adults with stage IV gastric cancer that cannot be operated on initially. The goal is to control the disease by converting…

This study is testing if giving a drug called trilaciclib before standard chemotherapy can protect patients' bone marrow and reduce severe side effects like infections and anemia. It will enroll about 40 adults with advanced non-small cell lung cancer. The main goal is to see if …